Watch Ticker

Trinity Biotech plc

Go to Trinity Biotech plc Website

$0.84

-0.06 (-6.67%)

Live

Previous Close

$0.899999

Day Range

$0.8356 - $0.85

Previous Day Range

$0.811 - $0.9106

Market Cap

$15.2 million USD

Day Vol.

71753

Previous Day Vol.

393410

Currency

USD

Primary Exchange

Nasdaq

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexua...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - Global Long-term Forecasts to 2028 and 2033

The global hemoglobin A1c (HbA1c) testing market is expected to grow from $1.66 billion in 2023 to $1.83 billion by 2024, driven by the increasing prevalence of diabetes and advancements in diagnostic technology. The Asia-Pacific region is anticipated to experience the fastest growth, while North America remains the largest market.

Related tickers: TMO, ABT, DHR, BIO, BIO.B, TRIB.

Read Full Article

Trinity Biotech Plc - Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Trinity Biotech has entered into amended agreements with its primary lender, Perceptive Advisors, to provide additional liquidity and support its Comprehensive Transformation Plan, which includes the development of its continuous glucose monitoring (CGM) technology.

Related tickers: TRIB.

Read Full Article

Trending Tickers

Please sign in to view